With regard to tryptophan metabolism in tumors, IDO also mediates immune suppressive effects of MDSCs in breast cancer and lung cancer [290, 291], and the upregulation of IDO in MDSCs depends on STAT3 phosphorylation [290]. This evidence concerns the gene IDO1 and breast carcinoma.